Use of annexins as a lupus anticoagulant control or standard in clotting tests
US6194214A · kind A · utility
8Cited by
7References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 10, 1998 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Aug 10, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/106664
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to a process for the production of plasmas with added annexins for use as a control or standard in all functional clotting tests which are used for the detection of a lupus anticoagulant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.